Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Waiting for a buy out?

No way. I think we'd need to get at least 3 times that much ($1.5B)to get $1.00 a share. Keep in mind that half would go to TPL and then expenses. Although I'd be OK with $0.50 (not happy)at this point. I'm sick of this drawn out fiasco.

GL

Share
New Message
Please login to post a reply